11 – 14 of 14
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- « previous
- 1
- 2
- next »
- 2015
-
Mark
Quantitative imaging by automated bone scan index (BSI) as a response biomarker in standard clinical care of patients with metastatic castration-resistant prostate cancer (mCRPC) treated with enzalutamide
2015) American Society of Clinical Oncology Genitourinary (ASCO GU) Cancers Symposium In Journal of Clinical Oncology 33(7 Suppl). p.288-288(
- Contribution to journal › Published meeting abstract
- 2014
-
Mark
Neuroendocrine Prostate Cancer: FDG-PET and Targeted Molecular Imaging
(
- Contribution to conference › Abstract
-
Mark
Molecular Imaging for Localized Prostate Cancer: Analysis of 2 Prospective Phase 0 Trials of PSMA Targeted Immuno-PET and –SPECT, and Implications for the Radiation Oncologist
2014) American Society for Radiation Oncology (ASTRO) 56th Annual Meeting In International Journal of Radiation Oncology Biology Physics 90(1 Suppl). p.208-208(
- Contribution to journal › Published meeting abstract
-
Mark
A Comparison of 111In-J591 SPECT with 89Zr-J591 PET Imaging for Prostate Cancer Patients
2014) American Urological Association (AUA) Annual Meeting In The Journal of urology 191(S4). p.602-603(
- Contribution to journal › Published meeting abstract
- « previous
- 1
- 2
- next »